Loading...
InnovaDerma PLC
IDP.L•LSE
Consumer Defensive
Household & Personal Products
£29.00
£0.00(0.00%)

The company's financials show resilient growth, with revenue advancing from $2.25B in Q3 2022 to $2.33B in Q2 2023. Gross profit remained healthy with margins at 65% in Q2 2023 compared to 64% in Q3 2022. Operating income hit $677.00M last quarter, sustaining a consistent 29% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $725.00M. Net income rose to $453.50M, while earnings per share reached $0.24. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan